Düdingen, 07.09.2023 – confinis ag, a global consulting firm specializing in medical devices, in vitro diagnostics, and combination products, is pleased to announce that Dr. Dario Motti has joined the company to lead the new Digital Health Competence Cluster. This strategic appointment is in line with confinis’s commitment to being at the forefront of the digital health revolution.

Dr. Motti holds a Ph.D. in Neuroscience from the International School of Advanced Studies in Trieste, Italy. He brings over 15 years of experience in pre-clinical and clinical research from various academic and private organizations across Italy, France, and the United States. Over the last seven years, he has dedicated himself to digital health and digital medical devices. His expertise covers a wide range of areas within the digital health solutions sphere, having participated in and led the development and validation of regulated digital products, including Digital Endpoints, Digital Therapeutics (DTx), Remote Patients Monitoring solutions (RPMs), and Clinical Decision Support tools and algorithms.

Prior to joining confinis, Dario led a team of software developers and data scientists at Vistronix (US) and spent five years at Roche, where he focused on Clinical Evidence and Clinical/Performance Evaluation for regulated digital solutions.

Dario’s passion for improving the lives of patients worldwide, especially those living with chronic conditions, aligns perfectly with the mission and vision of confinis. “I have been particularly interested in how the healthcare world can expand its value by leveraging digital technologies. From the moment I got to know confinis, its founder Beat, and its new CEO, Andrea, I felt a strong synergy between my passion and their mission and vision,” said Dario.

“Digital health has an enormous potential to change the healthcare world, but there are still a lot of challenges in an ever-changing regulatory space that is still learning and understanding the technology and its iterative and fast-paced nature” continues Dario. Helping companies to approach these challenges in a pragmatic but innovative way, by establishing the value of Artificial Intelligence and Machine-Learning algorithms is one of the objectives of the new cluster, that under Dario’s lead will also support the validation and commercialization of digital therapeutic solutions, as well as new digital drug development tools such as digital endpoints.

confinis’s CEO, Dr. Andrea Biasiucci, expressed his enthusiasm about the new appointment, “We are thrilled to have Dario join our team. His extensive experience and strategic approach to to clinical evidence for medical devices and digital health will be invaluable as we continue to support our clients in navigating the complex landscape of international regulations.”

For further information, please contact:

Sabrina Campana
Head of Communication
+41 78 797 2099

Download the press release in pdf here

About confinis:

confinis is a globally recognized consulting firm specializing in the field of medical devices, in vitro diagnostics, and combination products. With headquarters in Switzerland and a presence in the USA, confinis provides comprehensive and tailored solutions to meet the unique regulatory and quality challenges faced by organizations operating in these industries.